X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Motilal Oswal with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MOTILAL OSWAL vs INDOCO REMEDIES - Comparison Results

MOTILAL OSWAL    Change

Motilal Oswal Financial Services (MOFSL) derives a significant portion of its revenues from equity broking (69% in FY12) for both retail and institutional clients. Accordingly, its revenues and profits are dependent on favourable capital market condi... More

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MOTILAL OSWAL INDOCO REMEDIES MOTILAL OSWAL/
INDOCO REMEDIES
 
P/E (TTM) x 24.5 88.4 27.7% View Chart
P/BV x 4.4 3.2 137.6% View Chart
Dividend Yield % 0.7 0.7 92.5%  

Financials

 MOTILAL OSWAL   INDOCO REMEDIES
EQUITY SHARE DATA
    MOTILAL OSWAL
Mar-18
INDOCO REMEDIES
Mar-17
MOTILAL OSWAL/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs1,585360 439.8%   
Low Rs734249 294.7%   
Sales per share (Unadj.) Rs189.4119.0 159.1%  
Earnings per share (Unadj.) Rs38.78.4 462.8%  
Cash flow per share (Unadj.) Rs41.315.2 271.1%  
Dividends per share (Unadj.) Rs4.501.60 281.3%  
Dividend yield (eoy) %0.40.5 73.9%  
Book value per share (Unadj.) Rs156.470.7 221.1%  
Shares outstanding (eoy) m145.0892.15 157.4%   
Bonus/Rights/Conversions ESOS--  
Price / Sales ratio x6.12.6 239.1%   
Avg P/E ratio x30.036.4 82.2%  
P/CF ratio (eoy) x28.120.0 140.4%  
Price / Book Value ratio x7.44.3 172.1%  
Dividend payout %11.619.1 60.8%   
Avg Mkt Cap Rs m168,22828,083 599.0%   
No. of employees `000NA6.0 0.3%   
Total wages/salary Rs m5,0012,167 230.8%   
Avg. sales/employee Rs Th1,717,468.81,817.0 94,519.7%   
Avg. wages/employee Rs Th312,581.3359.0 87,079.0%   
Avg. net profit/employee Rs Th350,962.5127.7 274,868.3%   
INCOME DATA
Net Sales Rs m27,48010,968 250.5%  
Other income Rs m21740 547.4%   
Total revenues Rs m27,69711,007 251.6%   
Gross profit Rs m12,7791,565 816.8%  
Depreciation Rs m375633 59.2%   
Interest Rs m4,95662 7,980.5%   
Profit before tax Rs m7,666909 843.0%   
Minority Interest Rs m-980-   
Prior Period Items Rs m910-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,043139 1,473.2%   
Profit after tax Rs m5,615771 728.6%  
Gross profit margin %46.514.3 326.0%  
Effective tax rate %26.715.3 174.8%   
Net profit margin %20.47.0 290.8%  
BALANCE SHEET DATA
Current assets Rs m29,0195,725 506.9%   
Current liabilities Rs m41,8355,454 767.0%   
Net working cap to sales %-46.62.5 -1,889.6%  
Current ratio x0.71.0 66.1%  
Inventory Days Days062 0.1%  
Debtors Days Days13972 193.1%  
Net fixed assets Rs m3,1135,307 58.7%   
Share capital Rs m145184 78.7%   
"Free" reserves Rs m22,5406,331 356.0%   
Net worth Rs m22,6856,516 348.2%   
Long term debt Rs m32,3291,323 2,443.4%   
Total assets Rs m98,64511,970 824.1%  
Interest coverage x2.515.6 16.3%   
Debt to equity ratio x1.40.2 701.8%  
Sales to assets ratio x0.30.9 30.4%   
Return on assets %10.77.0 154.0%  
Return on equity %24.811.8 209.3%  
Return on capital %22.912.4 185.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m04,507 0.0%   
Fx outflow Rs m01,141 0.0%   
Net fx Rs m03,366 0.0%   
CASH FLOW
From Operations Rs m1,118886 126.1%  
From Investments Rs m-1,907-1,706 111.8%  
From Financial Activity Rs m7151,316 54.4%  
Net Cashflow Rs m-91497 -18.3%  

Share Holding

Indian Promoters % 74.1 59.2 125.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 12.5 60.0%  
FIIs % 5.3 6.0 88.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.1 22.4 58.5%  
Shareholders   11,283 12,805 88.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MOTILAL OSWAL With:   IL&FS INV. MANAGERS  MIC ELECTRONICS  GEOJIT FINANCIAL SERVICES  REPCO HOME  TIMKEN INDIA  



Today's Market

Sensex Ends Flat; IT & Energy Stocks Gain(Closing)

Indian share markets traded on a volatile note throughout the day and ended their session on a flat note. Sectoral indices ended on a mixed note with stocks in the IT sector.

Related Views on News

MOTILAL OSWAL 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of MOTILAL OSWAL for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of MOTILAL OSWAL. Also includes updates on the valuation of MOTILAL OSWAL.

INDOCO REMEDIES Announces Quarterly Results (2QFY19); Net Profit Down 139.4% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, INDOCO REMEDIES has posted a net profit of Rs 78 m (down 139.4% YoY). Sales on the other hand came in at Rs 2 bn (down 17.3% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

CreditAccess Grameen IPO: Should You Apply to this Interesting Microfinance Play? (IPO)

Aug 7, 2018

Should you apply to the IPO of CreditAccess Grameen Ltd?

HDFC AMC IPO: Do Valuations Leave Enough on Table for Investors? (IPO)

Jul 20, 2018

Should you subscribe to the IPO of HDFC AMC Ltd?

IndoStar Capital Finance IPO: Is This NBFC Worth Betting On? (IPO)

May 8, 2018

Should you apply for the IPO of IndoStar Capital Finance?

More Views on News

Most Popular

Our First Bluechip Stock Recommendation in Smart Money Secrets(The 5 Minute Wrapup)

Jan 9, 2019

For the first time, we have recommended a bluechip stock in Smart Money Secrets.

3 Stocks in Super Investor Sumeet Nagar's Portfolio That You Can Buy Right Now(The 5 Minute Wrapup)

Jan 11, 2019

The reasons that make these six stocks in Sumeet Nagar's portfolio so compelling

Follow a Super Investor Like This to Multiply Your Wealth(The 5 Minute Wrapup)

Jan 4, 2019

Following a super investor can certainly help build a portfolio and create wealth in the long term.

15 Mistakes to Avoid to Make a Killing in the Markets(Profit Hunter)

Jan 3, 2019

Richa dissects the common mistakes investors make and how to avoid and even take advantage of them.

My First Stock Trading Recommendation For 2019(Profit Hunter)

Jan 10, 2019

My first trading recommendation for 2019 is a bluechip auto stock. Find out everything about it right away.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

MOTILAL OSWAL SHARE PRICE


Jan 16, 2019 (Close)

TRACK MOTILAL OSWAL

  • Track your investment in MOTILAL OSWAL with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MOTILAL OSWAL - NESCO LIMITED COMPARISON

COMPARE MOTILAL OSWAL WITH

MARKET STATS